Sanofi India Limited Pharmaceuticals & Healthcare
- Submitted by: SophiaJones
- Views: 123
- Category: Other
- Date Submitted: 06/02/2016 03:27 AM
- Pages: 4
- Report this Essay
Market Reports on India presents the latest report on “Sanofi India Limited Pharmaceuticals & Healthcare Deals and Alliances Profile”. http://www.marketreportsonindia.com/life-sciences-market-research-reports-964/sanofi-india-limited.html The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
02nd June, 2016 – Navi Mumbai, India: Market reports on India present the latest report on “Sanofi India Limited Pharmaceuticals & Healthcare Deals and Alliances Profile”. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
Summary
Sanofi India Limited (Sanofi India), a subsidiary of Sanofi is a pharmaceutical company that manufactures medicines for the treatment of patients in several therapeutic areas. Its product portfolio includes ramipril, amlodipine, hydrochlorothiazide, frusemide, spironolactone, frusemide, piperacillin, tazobactam, cefpirome sulphate, meropenem, gemifloxacin, azithromycin, ofloxacin, levofloxacin, rabeprazole, domperidone and others. Sanofi India’s target therapy areas include cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, respiratory, dermatology, anti-infective diseases, orthopedic diseases, gastrointestinal disorders, and central nervous system. The company was formerly known as Aventis Pharma Limited. It has two state-of-the-art manufacturing facilities at Ankleshwar, Gujarat and Verna, Goa. Sanofi India is headquartered in Mumbai, Maharashtra, India.
Sanofi India Limited (SANOFI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year...
02nd June, 2016 – Navi Mumbai, India: Market reports on India present the latest report on “Sanofi India Limited Pharmaceuticals & Healthcare Deals and Alliances Profile”. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
Summary
Sanofi India Limited (Sanofi India), a subsidiary of Sanofi is a pharmaceutical company that manufactures medicines for the treatment of patients in several therapeutic areas. Its product portfolio includes ramipril, amlodipine, hydrochlorothiazide, frusemide, spironolactone, frusemide, piperacillin, tazobactam, cefpirome sulphate, meropenem, gemifloxacin, azithromycin, ofloxacin, levofloxacin, rabeprazole, domperidone and others. Sanofi India’s target therapy areas include cardiovascular disease, thrombotic diseases, metabolic disorders, oncology, respiratory, dermatology, anti-infective diseases, orthopedic diseases, gastrointestinal disorders, and central nervous system. The company was formerly known as Aventis Pharma Limited. It has two state-of-the-art manufacturing facilities at Ankleshwar, Gujarat and Verna, Goa. Sanofi India is headquartered in Mumbai, Maharashtra, India.
Sanofi India Limited (SANOFI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year...